The Softgel capsule market Size was valued at USD 7.3 billion in 2021 and is projected to grow from USD 7.87 Billion in 2022 to USD 13.9 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.7% during the forecast period (2023 - 2032). The rising prevalence of chronic diseases such as cardiovascular disease and diabetes, as well as the increasing number of softgel capsule clinical trials, are driving market demand.
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Vegetarian Softgel сарѕulеѕ or non-animal Softgel capsules are derived from natural plant sources, are free of аnіmаl dеrіvаtіvеѕ and GМО, and are free of gluten and modified sugars. One of the primary benefits of using cellulose-based or vegetarian capsules is that they are not made of animal byproducts. This distinct character makes them suitable for people who do not consume animal-sourced products. Vegetarian capsules stand out in terms of stability, solubility, and bioavailability. In terms of solubility, both capsules easily dissolve at body temperature. Vegan capsules, however, disintegrate more readily in water than gelatin-type caps at room temperature.
Vegetarian capsules are also 100% natural. Thus, no known potential health risk is associated with consuming them over an extended period. Vegetarian capsules are ideal for consumers looking for an animal-free alternative to gelatin capsules. The population is becoming increasingly interested in this broad range of products due to the advantages of vegan capsules. As a result, pharmaceutical companies see this as a profitable trend to market vegan capsules, capturing a significant share of the industry.
Increased R&D activities to support the use of Softgel capsules, a surge in demand for Softgel health supplements, a rise in consumer awareness of preventative healthcare, and the proliferation of distribution channels are other factors driving global Softgel capsules market growth in the forecast period. Furthermore, lifestyle changes, an increase in the geriatric population, and an increase in the number of self-directed consumers are some factors that have fueled market revenue growth.
Based on type, the softgel capsule market segmentation includes gelatin and non-animal types. The gelatin-type segment held the majority share in 2021, contributing to around ~70-72% of the softgel capsule market revenue. Gelatin is the preferred active ingredient among manufacturers owing to its unmatched benefits over other substances. The ease of digestion, tamper-evident capsule production, high mechanical resistance, high seal quality, patient compliance, abundant resource availability, and inert and clean-label raw material are all factors that contribute to the product's widespread market acceptability. Producers make capsules with bovine and porcine gelatin due to their unique properties. Bovine gelatin improves capsule stiffness, whereas porcine gelatin improves formulation fluidity and clarity. Despite the advantages of gelatin capsules, non-animal-based capsules experienced rapid growth during the forecast period. The market is expected to grow owing to increased consumer acceptance among vegetarians and growing research by leading industry competitors.
Figure 2: Softgel capsule market, by Type, 2021 & 2030 (USD Million)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
Based on application, the softgel capsule market segmentation includes vitamins, supplements, and nutrition. Vitamins dominated the global market in 2021 and are predicted to grow fastest from 2022 to 2030. Vitamins are susceptible to atmospheric oxidation and deterioration when made into tablets or gummies. Therefore, Softgel capsules are the best formulation option because they offer protection from oxidation and UV radiation, extending their shelf life. According to studies, vitamins may be absorbed into the bloodstream more quickly when given as Softgel capsules than tablets. These benefits have led to a large market size for vitamins in the application segment, where they are primarily sold in the form of soft gel capsules.
April 2020: ISDIN, a dermatology business in Spain, has announced the introduction of SunISDIN Softgel Capsules to the American market. It is a nutritional supplement that can be taken orally to aid in the fight against photoaging.
By Region, the study provides market insights into North America, Europe, Asia-Pacific, and the Rest of the World. The North American Softgel Capsule market accounted for USD 3.08 billion in 2021 and is anticipated to exhibit a significant CAGR growth over the projection period. Improved manufacturing technology, the presence of major regional players, and increased R&D spending to broaden their product portfolio. Moreover, the existence of health-conscious consumers and pharma leaders in the region are the primary factors responsible for the region's largest market share. The major regional pharmacy chains are also working to commercialize the capsules, creating lucrative opportunities to expand the soft gel capsule market revenue over the forecast period. Key regional players seek US FDA and other regulatory approvals to increase their base of customers in other regions.
In addition, the United States, Germany, Canada, France, the United Kingdom, India, Italy, Spain, Australia, Japan, South Korea, and Brazil are among the major nations covered in the market report.
Figure 3: SOFTGEL CAPSULE MARKET SHARE BY REGION 2021 (%)
Source: Secondary Research, Primary Research, MRFR Database, and Analyst Review
The European Softgel capsule market is the world's second-largest. Increased personalized medicine and high-tech processing spending to optimize soft gel production are expected to drive European market growth. Moreover, the increase in contract manufacturing organizations in the region provides a great opportunity for new entrants. The rapidly increasing prevalence of chronic diseases such as CVD, as well as growing population awareness about the consumption of various health and dietary supplements, are a few other factors that are likely to contribute to the market's expansion in this region. Furthermore, the UK Softgel capsule market held the largest market share, while the France Softgel capsule market is the fastest-growing market in the European region.
The Asia-Pacific Softgel Capsule Market is expected to grow at the fastest CAGR from 2022 to 2030. The large presence of generic pharmaceutical manufacturers in India and China, rising demand for cost-effective therapeutics, rapidly improving economic conditions, and increasing contract manufacturing organizations in the region all contribute to the region's rapid growth. In addition, the region's significant presence of several organizations actively involved in novel pharmaceutical industries will boost overall industry demand. Increasing awareness of highly developed doses from various disease treatments will drive market expansion. Additionally, growing healthcare expenditure, increasing disposable income, and favorable reimbursement scenarios are expected to drive the Softgel capsules market rate potential in the coming years. China’s Softgel capsule market held the largest market share, and the Indian Softgel capsule market was the fastest-growing market in the Asia-Pacific region.
Softgel Capsule Key Market Players & Competitive Insights
The softgel capsule market is extremely competitive owing to the presence of third-party manufacturers and SMEs. Large manufacturers are leading the way in embracing the outsourcing of Softgel capsules, which lowers their burden of equipment expenditure and ensures a competitive sales price to adhere in the competitive market. Market leaders conduct R&D to create Softgel capsules, tablets in capsules, and controlled-release medications for essential drugs to improve their product lineup and hold onto their leadership positions. Manufacturers in the Softgel capsule market focus on establishing a strong position by improving their production capabilities.
Manufacturers in the Softgel capsules market are increasing their product offerings with a diverse range of vegetarian Softgel capsules with improved properties like better resistance to gastric acid, rapid disintegration, enteric coating, and customized capsules for clinical trials to increase their market share. For instance, some businesses produce different kinds of vegetarian Softgel capsules, like pullulan, starch, and HPMC capsules. Furthermore, rising R&D investments by industry leaders and a growing population preference for natural products are boosting industry growth in the coming years.
Catalent Inc is an American multinational corporation company with headquarters in New Jersey. It is a leading global supplier of delivery technologies, gene therapies, biologics, drug development, and consumer health products. Catalent acquired a manufacturing plant in Oxfordshire in April 2022 to broaden biologics capabilities in the United Kingdom and Europe. Moreover, Catalent announced the launch of its OptiGel DR technology to formulate and produce enteric release Softgel in October 2020.
The Aenova Group is a market-leading contract manufacturer for the healthcare and pharmaceutical sectors. The Aenova Group declared the start of a new canning and bottling line for soft gelatin capsules at Cornu, Romania, in July 2021. It will increase the packaging department's capacity with cans and bottles, making it a one-stop shop for manufacturing and soft packaging capsules in all genetic variants. Moreover, in October 2021, Aenova, AlaskOmega AG, and Algarithm created and manufactured VegaGels containing omega-3 DHA fatty acids derived from microalgae. These vegan capsules are also chewable. The company's product portfolio has grown due to these product developments.
Key Companies in the Softgel capsule market include
Softgel Capsule Industry Developments
May 2022: Windzor Pharma Ltd introduced Solferol Softgel capsules, an Rx Vitamin D3 product, to the Irish market. It is one of the more affordable Solferol Softgel Vitamin D3 capsules.
November 2021: Roquette Pharmaceuticals has introduced a vegetarian Softgel containing pea-starch technology suitable for pharmaceutical and nutraceutical applications.
August 2021: Catalent Inc has announced its acquisition of Bettera Holdings LLC, a well-known nutritional supplement manufacturer. This has expanded the company's Softgel product offering and broadened its manufacturing capabilities.
| Report Attribute/Metric | Details |
| Market Size 2021 | USD 7.3 billion |
| Market Size 2022 | USD 7.87 billion |
| Market Size 2030 | USD 13.9 billion |
| Compound Annual Growth Rate (CAGR) | 7.7% (2023-2032) |
| Base Year | 2021 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018 & 2020 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Growth Factors, Market Competitive Landscape, Revenue Forecast, and Trends |
| Segments Covered | Type, Application, and Region |
| Geographies Covered | Europe, Asia Pacific, North America, and the Rest of the World |
| Countries Covered | The U.S, Germany, Canada, France, the UK, Spain, Italy, India, Japan, Australia, South Korea, China, and Brazil |
| Key Companies Profiled | Weihai Baihe Biology Technological Co. Ltd, Patheon, Catalent Inc, Captek Softgel International Inc, Capsugel, Amway, and EuroCaps Ltd |
| Key Market Opportunities | An increasing number of ongoing clinical trials and novel product launches in the industry Emerging developments of smart capsules for efficient drug delivery |
| Key Market Dynamics | A Rise in demand for Softgel health supplements Growing R&D activities to support the usage of Softgel capsules |
Softgel Capsule Market Highlights:
Frequently Asked Questions (FAQ) :
The softgel capsule market size was valued at USD 7.3 Billion in 2021.
The global market is projected to grow at a CAGR of 7.7% during the forecast period, 2023-2032.
North America had the largest share of the global market.
The key players in the market are Weihai Baihe Biology Technological Co. Ltd, Patheon, Catalent Inc, Captek Softgel International Inc, Capsugel, Amway, and EuroCaps Ltd.
The gelatin-type category dominated the market in 2021.
The vitamins had the largest share in the global market.
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
